Rankings
▼
Calendar
INMB
INmune Bio, Inc.
$38M
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$84,677
Net Income
-$134,677
EPS (Diluted)
$-0.03
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$247,542
Free Cash Flow
-$247,542
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$451,607
Total Liabilities
$600,810
Stockholders' Equity
-$149,203
Cash & Equivalents
$141,659
← FY 2016
All Quarters
Q1 2017 →
INMB Q4 2016 Earnings — INmune Bio, Inc. Revenue & Financial Results | Market Cap Arena
